NCT03461627View on ClinicalTrials.gov

Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma

PHASE3UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Asthma
Interventions
DRUG

Salmeterol Xinafoate and Fluticasone Propinate Powder

50ug/250ug 1 puff twice a day for 4 weeks

DRUG

Seretide

50ug/250ug 1 puff twice a day for 4 weeks

Trial Locations (1)

510120

RECRUITING

The First Affiliated Hospital Of Guangzhou Medical University, Guangzhou

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY